珈偉新能(300317.SZ):公司實控人達成紓困投資意向 或迎阜陽市潁泉區國資委入主
格隆匯1月7日丨珈偉新能(300317.SZ)公佈,公司於2022年1月7日收到公司實際控制人丁孔賢、李靂和丁蓓的通知,獲悉公司實際控制人與阜陽泉賦經過磋商,已就阜陽泉賦通過紓困投資方式取得公司控制權達成合作意向,後續紓困投資暨控制權變更的具體形式尚未確定,包括但不限於直接或間接受讓公司實際控制人持有的上市公司股票、表決權委託或其他紓困安排。
若該次紓困投資暨控制權變更事項完成,公司控制權將發生變更,阜陽泉賦將成為公司的控股股東,阜陽市潁泉區人民政府國有資產監督管理委員會成為公司的實際控制人,丁孔賢、李靂和丁蓓將不再為公司實際控制人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.